Studies have demonstrated that statins can decrease the number of tender joints, erythrocyte sedimentation rate, and C-reactive protein levels in RA patients, suggesting an anti-inflammatory benefit that could complement corticosteroid therapy20,21. This evidence concerns the gene CRP and rheumatoid arthritis.